LAURUSLABS2018-07-012018-09-30in-bse-fin:OneItemsThatWillNotBeReclassifiedToProfitAndLoss01Member LAURUSLABS2018-07-012018-09-30in-bse-fin:FourItemsThatWillNotBeReclassifiedToProfitAndLoss01Member LAURUSLABS2018-07-012018-09-30in-bse-fin:OneItemsThatWillBeReclassifiedToProfitAndLoss01Member LAURUSLABS2018-07-012018-09-30in-bse-fin:OneItemsThatWillBeReclassifiedToProfitAndLoss02Member LAURUSLABS2018-07-012018-09-30in-bse-fin:FourItemsThatWillBeReclassifiedToProfitAndLoss01Member LAURUSLABS2018-07-012018-09-30in-bse-fin:FourItemsThatWillBeReclassifiedToProfitAndLoss02Member iso4217:INRxbrli:purexbrli:sharesiso4217:INRxbrli:shares LAURUSLABS 2018-04-01 2019-03-31 2018-10-23 INR Millions Half yearly Single segment Pharmaceutical 2018-07-01 2018-09-30 Unaudited Standalone 5746340000.00 105100000.00 5851440000.00 3180000000.00 58310000.00 -150110000.00 678810000.00 240220000.00 389030000.00 1227740000.00 5624000000.00 227440000.00 0.00 227440000.00 30610000.00 20490000.00 51100000.00 0.00 176340000.00 0.00 0.00 0.00 176340000.00 -52330000.00 124010000.00 0.00 0.00 0.00 0.00 1064370000.00 10 1.66 1.66 0.00 0.00 1.66 1.66 Notes:1. The above standalone financial results of Laurus Labs Limited ("the Company") as reviewed by the Audit Committee has been approved by the Board of Directors at its meeting held on November 1, 2018. The statutory auditors of the Company have carried out a limited review on the standalone financial results and expressed an unmodified opinion thereon.(For Full Notes, please see the signed results sheet). 2018-04-01 2018-09-30 Unaudited Standalone 11057350000.00 130900000.00 11188250000.00 6018560000.00 85300000.00 -68850000.00 1365800000.00 457730000.00 761970000.00 2122080000.00 10742590000.00 445660000.00 0.00 445660000.00 76150000.00 33870000.00 110020000.00 0.00 335640000.00 0.00 0.00 0.00 335640000.00 -61480000.00 274160000.00 0.00 0.00 0.00 0.00 1064370000.00 10 3.16 3.16 0.00 0.00 3.16 3.16